Nome | Settore | Analyst Name | Analyst Job Title | Rating Quantitativo | Data | |
---|---|---|---|---|---|---|
Bristol-Myers Squibb Co | Salute | Karen Andersen | Director | 24/04/2025 | ||
CRISPR Therapeutics AG | Salute | Rachel Elfman | Equity Analyst | 24/04/2025 | ||
Merck & Co Inc | Salute | Karen Andersen | Director | 24/04/2025 | ||
Galderma Group AG Registered Shares | Salute | Diana Radu | Equity Analyst | 24/04/2025 | ||
Roche Holding AG | Salute | Karen Andersen | Director | 24/04/2025 | ||
Roche Holding AG ADR | Salute | Karen Andersen | Director | 24/04/2025 | ||
ResMed Inc | Salute | Shane Ponraj | Equity Analyst | 24/04/2025 | ||
ResMed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh | Salute | Shane Ponraj | Equity Analyst | 24/04/2025 | ||
Samsung BioLogics Co Ltd | Salute | Yurou Zheng | Equity Analyst | 24/04/2025 | ||
Edwards Lifesciences Corp | Salute | Debbie Wang | Senior Equity Analyst | 24/04/2025 | ||
Thermo Fisher Scientific Inc | Salute | Alex Morozov | Regional Director | 23/04/2025 | ||
Boston Scientific Corp | Salute | Debbie Wang | Senior Equity Analyst | 23/04/2025 | ||
Eurofins Scientific SE | Salute | Max Jousma | Equity Analyst | 23/04/2025 | ||
Intuitive Surgical Inc | Salute | Alex Morozov | Regional Director | 23/04/2025 | ||
Quest Diagnostics Inc | Salute | Debbie Wang | Senior Equity Analyst | 22/04/2025 | ||
Elevance Health Inc | Salute | Julie Utterback | Senior Equity Analyst | 22/04/2025 | ||
Getinge AB Class B | Salute | Max Jousma | Equity Analyst | 22/04/2025 | ||
Danaher Corp | Salute | Julie Utterback | Senior Equity Analyst | 22/04/2025 | ||
UnitedHealth Group Inc | Salute | Julie Utterback | Senior Equity Analyst | 17/04/2025 | ||
BioMerieux SA | Salute | Max Jousma | Equity Analyst | 17/04/2025 |